Breaking News Instant updates and real-time market news.

ACN

Accenture

$117.46

1.46 (1.26%)

, MCK

McKesson

$165.33

-0.49 (-0.30%)

07:36
10/11/16
10/11
07:36
10/11/16
07:36

Apigee to hold a conference

Adapt or Die Conference is being held in New York on October 11.

ACN

Accenture

$117.46

1.46 (1.26%)

MCK

McKesson

$165.33

-0.49 (-0.30%)

PBI

Pitney Bowes

$17.62

0.04 (0.23%)

GOOG

Alphabet

$785.94

10.86 (1.40%)

TRI

Thomson Reuters

$40.75

0.25 (0.62%)

APIC

Acquired by Google

$17.37

-0.01 (-0.06%)

  • 11

    Oct

  • 23

    Oct

  • 27

    Oct

  • 27

    Oct

  • 01

    Nov

  • 06

    Nov

  • 08

    Nov

  • 10

    Nov

  • 17

    Nov

  • 15

    Jan

ACN Accenture
$117.46

1.46 (1.26%)

07/12/16
PACS
07/12/16
INITIATION
Target $129
PACS
Overweight
Accenture initiated with an Overweight at Pacific Crest
Pacific Crest analyst Arvind Ramnani started Accenture with an Overweight rating and $129 price target.
07/12/16
PACS
07/12/16
INITIATION
PACS
Overweight
Accenture initiated at Pacific Crest
As noted earlier, Pacific Crest initiated coverage of Accenture with an Overweight rating. The firm expects the company's revenue to continue to grow going forward, driven partly by the quality of its global delivery model and increased demand in the wake of technological upgrades. Target $129.
09/08/16
WEDB
09/08/16
INITIATION
Target $125
WEDB
Outperform
Accenture initiated with an Outperform at Wedbush
Wedbush analyst Moshe Katri initiated Accenture with an Outperform and named it a Top Pick in IT Services with a $125 price target. The analyst expects Accenture to continue to benefit from recent SMAC investment as well as from its aggressive global delivery model which will likely provide incremental growth and scale. Katri recommends owning the stock post Q4 earnings on September 29, which he expects cautious guidance commentary but notes management has a long, consistent track record of returning cash to shareholders.
09/26/16
SOCG
09/26/16
UPGRADE
SOCG
Buy
Accenture upgraded to Buy from Hold at Societe Generale
MCK McKesson
$165.33

-0.49 (-0.30%)

09/27/16
COWN
09/27/16
NO CHANGE
COWN
Market Perform
Drag on drug distributors from brand inflation worries overdone, says Cowen
Cowen analyst Charles Rhyee said he views recent concerns over moderating brand inflation and their potential impact on drug distributors as "somewhat overblown," considering that he sees the issue as a 1%-2% headwind to adjusted EPS for the group. Additionally, Rhyee expects brand inflation to revert to normal levels once the current political rhetoric dies down. The analyst trimmed his price target on AmerisourceBergen (ABC) to $88 from $90, on Cardinal Health (CAH) to $86 from $89 and on McKesson (MCK) to $188 from $200 and keeps a Market Perform rating on all three stocks.
09/19/16
MSCO
09/19/16
NO CHANGE
MSCO
Drug Distributor price targets lowered at Morgan Stanley
Morgan Stanley analyst Ricky Goldwasser sees downside to December quarter earnings for distributors due to difficult year-over-year pricing comps. The analyst nows sees branded pricie moderation down 300 bps year-over-year versus 100bps previously as some drug manufacturers may be looking for moderating pricing practices following the Epipen controversy. As a result, Goldwasswer lowered estimates to reflect moderation in branded inflation and reduced price targets on McKesson (MCK) to $185 from $221, AmerisourceBergen (ABC) to $84 from $89, and Cardinal Health (CAH) to $82 from $91.
09/16/16
GSCO
09/16/16
DOWNGRADE
Target $189
GSCO
Neutral
McKesson downgraded to Neutral from Buy at Goldman
As previously reported, Goldman downgraded McKesson to Neutral from Buy and lowered its price target to $189 from $210. Analyst Robert Jones said softer brand price inflation presents additional risk to earnings, combined with headwinds from generics, M&A related contract losses, and foreign exchange. The analyst does not foresee any compelling earnings drivers outside of unknown M&A or capital deployment to push shares higher.
10/05/16
UBSW
10/05/16
INITIATION
Target $182
UBSW
Neutral
McKesson initiated with a Neutral at UBS
Target $182.
PBI Pitney Bowes
$17.62

0.04 (0.23%)

02/03/16
BMUR
02/03/16
NO CHANGE
Target $25
BMUR
Buy
Pitney Bowes shares 'absolutely oversold,' says Brean Capital
Brean Capital analyst Ananda Baruah said shares of Pitney Bowes, which are down roughly 30% since its earnings miss, are "absolutely oversold." The analyst said all of the incremental earnings dynamics the company guided to at its analyst day are manifesting as anticipated. Baruah said the two most important aspects of the business, the core metering business and eCommerce, are actually outperforming. Brean Capital reiterated its Buy rating and lowered its price target to $25 from $30 on Pitney Bowes shares.
GOOG Alphabet
$785.94

10.86 (1.40%)

09/28/16
MZHO
09/28/16
DOWNGRADE
Target $15
MZHO
Underperform
Mizuho cuts Twitter to Underperform with $15 price target
Mizuho analyst Neil Doshi downgraded Twitter to Underperform from Neutral based on valuation. The shares are up 45% since the company reported Q2 results, primarily driven by potential buyout comments in media reports, Doshi tells investors in a research note. The stock at current levels is overvalued as Twitter's business fundamentals "have deteriorated significantly" over the past 12 months, the analyst contends. Doshi believes many of the M&A scenarios are unlikely to play out. He puts potential acquirers Salesforce (CRM) and Alphabet (GOOG, GOOGL) in the "maybe" camp, but he still has some reservations about these deals happening. The analyst believes investors of both companies would view a buyout of Twitter as negative. Doshi keeps a $15 price target for Twitter shares. The stock closed yesterday up 35c to $23.72. Loop Capital this morning also downgraded Twitter to Sell.
09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/16
SBSH
10/06/16
NO CHANGE
Target $89
SBSH
Buy
Citi says Salesforce buying Twitter 'nearly impossible' above $28/share
Citi analyst Walter Pritchard believes a Salesforce (CRM) acquisition of Twitter (TWTR) is possible financially but that such a deal would put "significant constraints" on the company for the next three-plus years. The analyst sees "very little reason" for Salesforce to own Twitter and feels the acquisition "would pose a difficult decision" for CEO Marc Benioff and the board. Salesforce closed yesterday down 6%, or $4.21, to $68.42. Recode reported last night that the company is likely the only bidder left for Twitter after Disney (DIS) and Alphabet (GOOG) opted not to pursue a deal while Apple (AAPL) is unlikely. Twitter in pre-market trading is down 14% to $21.50. In order for Salesforce to avoid a shareholder vote, it would have to borrow $7.5B to fund the transaction if Twitter were valued at $20B, or $27.50-$28 per share, Pritchard tells investors in a research note. This is a level that likely constrains the company with little additional borrowing capacity for other deals, the analyst contends. He thinks the deal is "nearly impossible to do" for Salesforce should the bidding for Twitter go above $20B or $28 per share. Pritchard has a Buy rating on Salesforce with an $89 price target.
10/10/16
WELS
10/10/16
NO CHANGE
WELS
Alphabet, Facebook can meet Street estimates, says Wells Fargo
Wells Fargo says that investors are concerned about the ability of Facebook (FB) and Google (GOOG,GOOGL) to meet Street estimates because forecasts continue to indicate that TV's ad share will be relatively stable over the next two years. But Wells says that Facebook and Google will continue to gain share from "non-TV media" and could see increased revenue from "non-advertising marketing services" such as sponsorships and public relations. Wells keeps Outperform ratings on both stocks.
TRI Thomson Reuters
$40.75

0.25 (0.62%)

01/07/16
01/07/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 1st Constitution Bancorp (FCCY) downgraded to Market Perform at Raymond James... Alaska Air (ALK) downgraded to Neutral from Outperform at Credit Suisse... Alexion (ALXN) downgraded to Neutral from Buy at BTIG... Anadarko (APC) downgraded to Hold from Buy at Deutsche Bank... Apple Hospitality REIT (APLE) downgraded to Neutral from Outperform at Baird... Aqua America (WTR) downgraded to Neutral from Buy at Ladenburg... ArcBest (ARCB) downgraded to Equal Weight from Overweight at Stephens... Ashford Hospitality Prime (AHP) downgraded to Underperform from Neutral at Baird... Broadcom (BRCM) downgraded to Market Perform from Outperform at Bernstein... Brown & Brown (BRO) downgraded to Neutral from Buy at SunTrust... Caladrius (CLBS) downgraded to Hold from Buy at Maxim... Capital One (COF) downgraded to Hold from Buy at Deutsche Bank... DDR Corp. (DDR) downgraded to Neutral from Outperform at Baird... Everyday Health (EVDY) downgraded on salesforce issues at Stifel... Expeditors (EXPD) downgraded to Sell from Neutral at UBS... First Community (FCCO) downgraded to Market Perform from Outperform at Raymond James... Genesee & Wyoming (GWR) downgraded to Sector Perform from Outperform at RBC Capital... HP Inc. (HPQ) downgraded to Market Perform from Outperform at Wells Fargo... Heartland Express (HTLD) downgraded to Underperform from Sector Perform at RBC Capital... Highwoods Properties (HIW) downgraded to Neutral from Outperform at Baird... Horizon Bancorp (HBNC) downgraded to Hold from Buy at Sandler O'Neill... Hubbell (HUBB) downgraded to Neutral from Overweight at JPMorgan... Illumina (ILMN) downgraded to Market Perform from Outperform at Wells Fargo... Kite Realty Trust (KRG) downgraded to Neutral from Outperform at Baird... Mondelez (MDLZ) downgraded to Hold from Buy at Deutsche Bank... Moody's (MCO) downgraded to Neutral from Overweight at Piper Jaffray... Morgan Stanley says Nordstrom (JWN) not immune from industry headwinds, cuts to sell... National Retail Properties (NNN) downgraded to Market Perform from Outperform at Raymond James... Navios Maritime (NM) downgraded to Sell on cash burn at Stifel... Newmont Mining (NEM) downgraded to Sector Perform from Outperform at RBC Capital... Nordstrom (JWN) downgraded to Underweight from Equal Weight at Morgan Stanley... Old Dominion (ODFL) downgraded to Sector Perform from Outperform at RBC Capital... Paychex (PAYX) downgraded to Underperform from Neutral at BofA/Merrill... PerkinElmer (PKI) downgraded to Market Perform from Outperform at Cowen... Piedmont Office Realty (PDM) downgraded to Neutral from Outperform at Baird... Post Properties (PPS) downgraded to Market Perform from Outperform at Raymond James... Public Storage (PSA) downgraded to Market Perform from Outperform at Raymond James... Rush Enterprises (RUSHA) downgraded to Sector Perform from Outperform at RBC Capital... Ryder (R) downgraded to Sector Perform from Outperform at RBC Capital... Saia, Inc. (SAIA) downgraded to Equal Weight from Overweight at Stephens... Scorpio Bulkers (SALT) downgraded to Hold from Buy at Stifel... Spirit Realty (SRC) downgraded to Neutral from Outperform at Baird... Star Bulk Carriers (SBLK) downgraded to Hold from Buy at Stifel... Stryker (SYK) downgraded to Market Perform from Outperform at Northland... Swift Transport (SWFT) downgraded to Sector Perform from Outperform at RBC Capital... Team (TISI) downgraded to Hold from Buy at BB&T... Terreno Realty (TRNO) downgraded to Neutral from Outperform at Baird... Thomson Reuters (TRI) downgraded to Neutral from Buy at BofA/Merrill... UBS (UBS) downgraded to Equal Weight from Overweight at Barclays... WebMD (WBMD) downgraded to Hold from Buy at Stifel... Whiting USA Trust II (WHZ) downgraded to Underperform at Raymond James... Zimmer Biomet (ZBH) downgraded to Market Perform from Outperform at Northland.
06/27/16
TDSI
06/27/16
DOWNGRADE
TDSI
Hold
Thomson Reuters downgraded to Hold from Buy at TD Securities
TD Securities analyst Vince Valentini downgraded Thomson Reuters to Hold citing Brexit and macro uncertainty.
08/25/16
MACQ
08/25/16
INITIATION
MACQ
Neutral
Thomson Reuters initiated with a Neutral at Macquarie
01/07/16
BOFA
01/07/16
DOWNGRADE
BOFA
Neutral
Thomson Reuters downgraded to Neutral from Buy at BofA/Merrill
APIC Acquired by Google
$17.37

-0.01 (-0.06%)

09/15/16
ROTH
09/15/16
DOWNGRADE
Target $17.4
ROTH
Neutral
Apigee downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst Richard Baldry downgraded Apigee (APIC) to Neutral from Buy citing its recently announced deal to be acquired by Google (GOOG; GOOGL) for $17.40 in an all-cash deal. The analyst believes the deal will be consummated as announced.
09/15/16
PACS
09/15/16
DOWNGRADE
PACS
Sector Weight
Apigee downgraded to Sector Weight from Overweight at Pacific Crest
Pacific Crest analyst Ben McFadden downgraded Apigee (APIC) to Sector Weight citing the acquisition by Google (GOOG, GOOGL). The analyst views a higher bid as unlikely.
10/10/16
JMPS
10/10/16
DOWNGRADE
JMPS
Market Perform
Apigee downgraded to Market Perform from Outperform at JMP Securities
JMP Securities downgraded Apigee (APIC) to Neutral to reflect Google's (GOOGL) acquisition of the company for $17.40 per share.
09/15/16
FBCO
09/15/16
DOWNGRADE
Target $17.4
FBCO
Neutral
Apigee downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Michael Nemeroff downgraded Apigee (APIC) to Neutral to reflect Google's (GOOGL) acquisition of the company for $17.40 per share.

TODAY'S FREE FLY STORIES

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

17:22
12/02/16
12/02
17:22
12/02/16
17:22
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

, IM

Ingram Micro

$38.88

1.31 (3.49%)

17:21
12/02/16
12/02
17:21
12/02/16
17:21
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

17:20
12/02/16
12/02
17:20
12/02/16
17:20
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:16
12/02/16
12/02
17:16
12/02/16
17:16
Periodicals
President Obama blocks China's takeover of Aixtron, CNBC reports »

Says the transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.74

-0.32 (-1.99%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Periodicals
Deutsche Bank to pay $60M settlement over gold price-fixing case, Reuters says »

Deutsche Bank will pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

ALB

Albemarle

$84.86

-0.79 (-0.92%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Hot Stocks
Albemarle to increase prices for select brominated products »

Albemarle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

FOR

Forestar Group

$13.40

0.2 (1.52%)

17:06
12/02/16
12/02
17:06
12/02/16
17:06
Hot Stocks
Breaking Hot Stocks news story on Forestar Group »

Carlson Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$108.14

-1.86 (-1.69%)

17:04
12/02/16
12/02
17:04
12/02/16
17:04
Syndicate
Breaking Syndicate news story on Diamondback Energy »

Diamondback Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSIR

Osiris

$5.68

0.06 (1.07%)

17:02
12/02/16
12/02
17:02
12/02/16
17:02
Hot Stocks
Osiris: Nasdaq grants company's request for additional time »

Osiris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STOR

STORE Capital

$24.45

0.52 (2.17%)

17:00
12/02/16
12/02
17:00
12/02/16
17:00
Hot Stocks
STORE Capital director Donovan acquires 4,350 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARB

Carbonite

$17.95

0.25 (1.41%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
Breaking Hot Stocks news story on Carbonite »

Crosslink lowers stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIB

CGI Group

$47.11

0.16 (0.34%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
CGI Group announces specific share repurchase program »

CGI Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.